External validation was achieved using 313 glioma samples from CGGA, and the time-dependent ROC curve similarly validated the efficient predictive efficacy of ATP6V1G2 on glioma prognosis (Fig. 9B). The gene discussed is ATP6V1G2; the disease is central nervous system cancer.